In this real-world cohort of HF patients prospectively enrolled across two different countries, the risk of 1-year ACM was lower among women with AHF and kidney dysfunction.
Schukraft et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: